
The suprachiasmatic nucleus (SCN) is the principal circadian clock in the mammalian brain. This structure is synchronized to the light-dark cycle through the retinohypothalamic tract (RHT), which releases glutamate onto the ventral SCN. Glutamate activates N-methyl-D-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors, increasing intracellular calcium levels and activating signaling pathways required for light-induced phase shifts. NMDA receptors are composed of different subunits: GluN1, GluN2 (A-D), and GluN3 (A-B). However, it remains unknown whether GluN3-containing NMDA receptors are present in SCN neurons and, if so, whether these subunits are functional and contribute to glutamatergic signaling in the ventral SCN. To address these questions, we used immunohistochemistry to assess GluN3 expression in the ventral and dorsal SCN and whole-cell patch-clamp recordings in the ventral SCN to monitor stimulus-evoked asynchronous excitatory postsynaptic currents (aEPSCs) following repetitive electrical stimulation of the RHT. Analyses of GluN3A and GluN3B expression disclosed higher levels of both subunits, as well as higher numbers of immunopositive particles during daytime vs nighttime in the ventral SCN. In contrast, the dorsal SCN showed a reversed pattern, with higher GluN3A expression during the night. Electrophysiological experiments showed that CGP-78608, an antagonist of the GluN1 glycine-binding site and a positive allosteric modulator of GluN3A-mediated responses, reduced the frequency and amplitude of aEPSCs during daytime, but not during nighttime. Moreover, bath application of glycine, which activates the GluN3 subunit, increased the frequency and amplitude of aEPSCs during the day, but not during the night. Finally, the antagonist 5,7-Dichlorokynurenic acid (DCKA) completely abolished the remaining aEPSCs at both times analyzed, further supporting the contribution of GluN3-containing NMDA receptors to these responses. Our findings support that GluN3 subunits are expressed in both ventral and dorsal SCN neurons and that GluN3-containing receptors are functionally involved in the glutamatergic signaling of the ventral SCN, depending on the circadian time (day vs night, at least).
The use of genetically introduced optical reporters has improved understanding of circadian rhythms at the cellular and systems levels, but the use of this approach in mammals has been limited to mice and rats. The Syrian hamster ( Mesocricetus auratus ) has been a long-standing circadian model due to its rhythmic precision and physiological responses to photoperiod. Here we report the development of the Per2 LUC hamster, which harbors a knock-in construct inserted using the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology. We test circadian and photoperiodic function at the behavioral level in the Per2 LUC hamster and evaluate ex vivo Per2 -driven bioluminescence rhythms across a variety of tissues. Our results indicate modest effects of transgene insertion on circadian function in vivo and provide evidence that ex vivo Per2 -driven bioluminescence rhythms are robust to dissection for many of the 10 tissues examined here. Properties of bioluminescence rhythms varied by tissue type in the Per2 LUC hamster, which was overall similar to those displayed by tissues collected from the Per2 LUC mouse. Collectively, these results indicate that this new animal model may be beneficial in both circadian and non-circadian applications in future studies.
The mechanisms underlying seasonal mood variation are incompletely characterised. We tested whether wearable-measured sleep, activity, circadian and light exposure patterns are associated with seasonal mood variation in young Australians with emerging mood disorders. We analysed 733 observation periods from 422 participants (mean age 24.3 ± 5.5 years; 63% female) attending early-intervention clinics. Each observation included a clinical assessment paired with ≥5 valid days of wrist actigraphy. Season was modelled using sine-cosine functions of day-of-year. Sleep, activity and circadian features were reduced using joint and individual variation explained (JIVE). Light exposure features were reduced using principal component analysis (PCA) applied to light regularity, timing and exposure interval across 7 illuminance thresholds. Linear mixed-effects models tested seasonal effects on clinical outcomes; indirect associations for 12 candidate JIVE/PCA variables were estimated by cluster bootstrap. Depressive symptoms (β = −0.67, P = .023) and negative symptoms (β = −0.17, P = .041) peaked in winter, whereas manic symptoms peaked in autumn (β = 0.24, P = .019). Winter increases in negative symptoms were associated with an ‘extended sleep with phase-delayed activity’ profile (indirect β = −0.015, P < .002) and a ‘constrained pattern of moderate-to-bright indoor light exposure’ profile (indirect β = −0.038, P = .002), reflecting high day-to-day consistency with a narrow daily exposure window. The light association persisted after adjustment for time spent above the light threshold, which itself was not associated with symptoms. Winter increases in depressive symptoms were associated with lower overall physical activity levels (indirect β = −0.009, P = .040). No indirect associations were identified for manic symptoms. In this transdiagnostic youth sample, seasonal variation in mood was modest but was accompanied by differences in how personal light exposure was arranged across the day, not only in how much light was received and in daily activity patterns. These cross-sectional associations identify light patterning and activity rhythms as candidate modifiable targets for prospective and interventional research.
The well-known bidirectional link between seizures and sleep may be most conspicuous in environments where the chief zeitgeber – sunlight – undergoes extreme but consistent changes over the course of a year. Routine circannual encounters with the midnight sun and midday darkness strategically position Earth’s polar regions as natural laboratories to study this effect. We reviewed 2337 studies that related status epilepticus (SE), light exposure, and sleep in people in the Arctic or Antarctic. Status epilepticus represented the most extreme – and arguably incontrovertible – expression of seizure. After applying filters and exclusion criteria, 5 studies were included for SE and 36 for sleep. Status epilepticus was correlated with increasing daylength going into summer (ie, brighter sunlight vector ) at high latitudes. Sunlight and chronotype demonstrated a linear relationship, with more sunlight going into summer (ie, brighter sunlight vector) advancing chronotype, less sunlight going into winter (ie, darker sunlight vector ) delaying chronotype, and extreme cases becoming free-running in either vector direction. U-shaped relationships were also surmised, with increased sleep fragmentation and decreased sleep duration for both brighter and darker sunlight vectors. A parsimonious synthesis is that a brighter sunlight vector advances chronotype to shorten and fragment sleep, thereby triggering more SE and seizures. Although these data are derived from Earth’s poles, they are not specific to polar regions; rather, they hold ramifications for everyone on planet Earth – 1 in 10 of whom will have a seizure in their lifetime.